Metformin and Esomeprazole For Preterm Pre-eclampsia

Status unconfirmed · Phase 1

Conditions studied: Preeclampsia Severe, Preeclampsia Second Trimester, Preterm Birth Complication

In brief

A recent randomized controlled trial by Cluver et al included 180 women with preterm pre-eclampsia between 26+0 to 31+6 weeks' gestation undergoing expectant management: 90 were randomised to extended release metformin and 90 to placebo. Investigators found that extended release metformin (3g daily) can prolong gestation in women with preterm pre-eclampsia. Combination metformin and esomeprazole has shown promise in the treatment of preeclampsia as both agents reduce placental and endothelial secretion of soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin, and reduce endothelial dysfunction.

Key facts

Study ID
NCT05232994
Run by
Christiana Care Health Services
People needed
38
Starts
2023-03-01
Expected to finish
2025-12-31
Last updated by the study team
2023-02-10

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.